COSCIENS Biopharma Inc (CSCI)

[meistermell]

This has always been a risky company riddled with dilution and failures. Clearly the market expects Zoptrex to fail, but the longer than expected duration may point to superior efficacy. I don't think it will retrace much maybe bounce around $2 or $2.50 for a while. Scalped a little AH to take minor losses and reduce cost basis and will stay in with a small play. But anybody should only hold now if they can clearly afford to lose it all. Or buy call options if there are any as mentioned. The pot odds for Zoptrex are still great, looking at a 10-20 bagger or more in case of success a single small bet is warranted if you believe the trial has 20% chance to succeed or more. History of AEZS points to failure, the length of the trial and recent insider buys/option awards (it's blinded though) may point to decent odds of success unless you attribute it all to placebo. GL and don't bet the farm ;)